Tweet
Masked or unmasked genome for ChIP-seq analysis?
Should I use the masked genome or not (chromFaMasked vs. chromFa; both from UCSC) to align my chIP-seq data? If it depends on the alignment programs? Thanks!
-
-
I would think this would depend on the aligner you're using, and what you plan to do with multi-match reads.
Depending on what you've precipitated in your ChIP, You're probably more interested in unique regions, anyhow, so I don't think it will make a big difference for the most part. If you were working with whole genome or wtss, I would expect it to have a bigger impact.The more you know, the more you know you don't know. —Aristotle -
Definitely unmasked. The repeats masked by repeatmasker (alu, line, sine, mir etc) do contain unque sequences, and probably using masked reference would lead to false alignments of reads from repeats if you allow several mismatches. chr.fa files are also repeatmasked but to lowercase rather than N:s so this information can still be used by some aligners-Comment
-
If you're allowing multiple matches in a ChIP-Seq experiment, how are you interpreting them?
AnthonyThe more you know, the more you know you don't know. —AristotleComment
-
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...Today, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...Yesterday, 05:17 AM -
Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.07-01-2026, 11:43 AM
Comment